(19)
(11) EP 1 751 289 A1

(12)

(43) Date of publication:
14.02.2007 Bulletin 2007/07

(21) Application number: 05751967.0

(22) Date of filing: 18.05.2005
(51) International Patent Classification (IPC): 
C12N 15/86(2006.01)
A61K 39/12(2006.01)
C12N 5/10(2006.01)
A61K 48/00(2006.01)
(86) International application number:
PCT/US2005/017766
(87) International publication number:
WO 2005/113782 (01.12.2005 Gazette 2005/48)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

(30) Priority: 18.05.2004 US 572212 P

(71) Applicant: Alphavax, Inc.
Research Triangle Park, NC 27709-0307 (US)

(72) Inventors:
  • RAYNER, Jon, O.
    Apex, NC 27502 (US)
  • SMITH, Jonathan, F.
    Cary, NC 27511 (US)
  • HUBBY, Bolyn
    Chapel Hill, NC 27514 (US)
  • REAP, Elizabeth, A.
    Durham, NC 27713 (US)

(74) Representative: O'Connell, Maura et al
F. R. Kelly & Co., 27 Clyde Road, Ballsbridge
Dublin 4
Dublin 4 (IE)

   


(54) TC-83-DERIVED ALPHAVIRUS VECTORS, PARTICLES AND METHODS